-
53601
Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-...
Published 2017“…</p><p>INTERPRETATION: These analyses illustrate the so-called nocebo effect, with an excess rate of muscle-related AE reports only when patients and their doctors were aware that statin therapy was being used and not when its use was blinded. these results will help assure both physicians and patients that most AEs associated with statins are not causally related to use of the drug and should help counter the adverse effect on public health of exaggerated claims about statin-related side-effects. …”
Journal article -
53602
-
53603
-
53604
-
53605
-
53606
-
53607
-
53608
-
53609
-
53610
-
53611
-
53612
-
53613
-
53614
-
53615
-
53616
-
53617
-
53618
-
53619
-
53620